National Polyp Study Data

Evidence for Regression of Adenomas

Published in: International Journal of Cancer, v. 111, no. 4, May 2004, p. 633-639

Posted on RAND.org on December 31, 2003

by Franka Loeve, Rob Boer, Ann G. Zauber, Marjolein van Ballegooijen, Gerritt J van Oortmarssen, Sidney J. Winawer, John Dik F Habbema

Read More

Access further information on this document at International Journal of Cancer

This article was published outside of RAND. The full text of the article can be found at the link above.

The data of the National Polyp Study, a large longitudinal study on surveillance of adenoma patients, is used for testing assumptions on the adenoma-carcinoma sequence. The observed adenoma and colorectal cancer incidence in the National Polyp Study were compared with the simulated outcomes of the MISCAN-COLON model of epidemiology and control of colorectal cancer for the U.S. population based on expert opinion. Variants of this model were explored in order to identify assumptions on the adenoma-carcinoma sequence that are consistent with the study observations. The high observed adenoma detection rates at surveillance and low observed colorectal cancer incidence in the National Polyp Study could only be explained by assuming a high incidence rate of adenomas accompanied by regression of adenomas. The National Polyp Study data suggest that adenoma prevalence results from a dynamic process of both formation as well as regression of adenomas. This lowers the expectations for the effects of colorectal cancer screening strategies that focus on adenoma detection.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.